NCT02675790 Moderate Dose Hydroxyurea for Secondary Stroke Prevention in Children With Sickle Cell Disease in Sub-Saharan Africa Status COMPLETED Phase PHASE3
NCT02565849 Study of Ventilatory Mechanics in Patients With Sickle Cell Anemia Status COMPLETED Phase N/A
NCT02556099 EXTEND EXpanding Treatment for Existing Neurological Disease Status COMPLETED Phase PHASE2
NCT02467257 Gum Arabic as Fetal Hemoglobin Agent in Sickle Cell Anemia Status COMPLETED Phase PHASE1/PHASE2
NCT02445144 Establishment of Functional MRI Imaging Parameters for Use in the Evaluation of Sickle Cell Disease Status TERMINATED Phase N/A
NCT02433158 Safety of Rivipansel (GMI-1070) in the Treatment of One or More Vaso-Occlusive Crises in Hospitalized Subjects With Sickle Cell Disease Status TERMINATED Phase PHASE3
NCT02149537 Risk Clinical Stratification of Sickle Cell Disease in Nigeria, Assessment of Efficacy/Safety of Hydroxyurea Treatment Status COMPLETED Phase PHASE4
NCT02090296 Risk-based Therapy for Sickle Cell Anemia: A Feasibility Study Status WITHDRAWN Phase PHASE2
NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions Status COMPLETED Phase N/A